Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (141-150 of 1,048) with videos related to

Pageof 105
Sort By:
Biochemistry|February 2, 1971
Studies on the allosteric properties of nuclear exoribonuclease from Ehrlich ascites tumorH M Lazarus, M B Sporn
AORN Journal|November 1, 1974
Vascular access in hemodialysisJ M Lazarus, A P Morgan
The Western Journal of Medicine|July 1, 1988
Irreversible interstitial pneumonitis associated with tocainide therapyB Van Natta, M Lazarus, C Li
Bone Marrow Transplantation|May 10, 2016
Peer review in hematopoietic cell transplantation: are we doing our fair share?S Giralt, R Korngold, H M Lazarus
Bone Marrow Transplantation|November 5, 2003
Myeloablative conditioning regimens for AML allografts: 30 years laterV Gupta, H M Lazarus, A Keating
Advances in Renal Replacement Therapy|January 30, 1999
The role of providers in implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative: Fresenius Medical Care North America perspectiveJ M Lazarus, G Wick, L Borella
Lancet (London, England)|April 10, 1982
Virus-like inclusions in osteosarcoma cells arising in Paget's diseaseM V Viola, G EIlon, M Lazarus
Bone Marrow Transplantation|March 1, 2017
Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapyB Gyurkocza, H M Lazarus, S Giralt
Bone Marrow Transplantation|March 7, 2003
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatmentJ Filicko, H M Lazarus, N Flomenberg
Bone Marrow Transplantation|May 30, 2003
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?P Mollee, H M Lazarus, J Lipton
Pageof 105

Showing results (141-150 of 1,048) with videos related to

Sort By:
Pageof 105
Biochemistry|February 2, 1971
Studies on the allosteric properties of nuclear exoribonuclease from Ehrlich ascites tumorH M Lazarus, M B Sporn
AORN Journal|November 1, 1974
Vascular access in hemodialysisJ M Lazarus, A P Morgan
The Western Journal of Medicine|July 1, 1988
Irreversible interstitial pneumonitis associated with tocainide therapyB Van Natta, M Lazarus, C Li
Bone Marrow Transplantation|May 10, 2016
Peer review in hematopoietic cell transplantation: are we doing our fair share?S Giralt, R Korngold, H M Lazarus
Bone Marrow Transplantation|November 5, 2003
Myeloablative conditioning regimens for AML allografts: 30 years laterV Gupta, H M Lazarus, A Keating
Advances in Renal Replacement Therapy|January 30, 1999
The role of providers in implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative: Fresenius Medical Care North America perspectiveJ M Lazarus, G Wick, L Borella
Lancet (London, England)|April 10, 1982
Virus-like inclusions in osteosarcoma cells arising in Paget's diseaseM V Viola, G EIlon, M Lazarus
Bone Marrow Transplantation|March 1, 2017
Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapyB Gyurkocza, H M Lazarus, S Giralt
Bone Marrow Transplantation|March 7, 2003
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatmentJ Filicko, H M Lazarus, N Flomenberg
Bone Marrow Transplantation|May 30, 2003
Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?P Mollee, H M Lazarus, J Lipton
Pageof 105